In this episode of SurgOnc Today®, members of the Society of Surgical Oncology’s Disease Site Working Group will discuss several presentations from the ASBrS 2025 meeting that have significant implications for current practice or are potential inflection points for breast surgical oncologists in the future.

In this episode of SurgOnc Today, Dr. Miral Grandhi of Rutgers University and Dr. Neha Lad of Mount Sinai Medical Center—both members of the HPB Disease Site Working Group—provide a curated summary of the most impactful hepato-pancreato-biliary malignancy papers presented at the Society of Surgical Oncology’s 2025 Annual Meeting in Tampa, Florida. The discussion is moderated by Dr. Patricio Polanco of UT Southwestern Medical Center, who also serves as Vice Chair of the HPB Disease Site Working Group.

In this new episode of Speaking of SurgOnc, Dr. Rick Greene discusses with Dr. Pedro Dos Santos the results of a study that examined whether patients of the lowest income quartile with stage IA NSCLC experience worse survival after resection when compared to higher-income patients, as well as other identified survival disparities, as reported in as reported in the article article, "Money Matters: The Effect of Income on Postsurgical Outcomes in Stage IA Non-small Cell Lung Cancer.”

In this podcast, Dr. Adam Khader (Richmond VA Medical Center & Assistant Professor at VCU School of Medicine) moderates a focused discussion with Dr. Jula Veerapong (UC San Diego Health) and Dr. Zachary Brown (NYU Langone Medical Center) on the clinical assessment and treatment of goblet cell carcinoma (GCC). The panel explores how evolving pathologic classifications impact management, the role of staging, and treatment considerations including systemic therapy and surgery. This episode provides practical, expert-driven insights for clinicians managing patients with this rare appendiceal malignancy.

In this episode of SurgOnc Today's Surgical Oncology Insight series, Dr. Peter Kingham, Section Editor of the Global Oncology Editorial Board section, discusses with Dr. Olusegun Alatise the the landscape of hepato-pancreato-biliary disease in West Africa and the available infrastructure to mitigate it, as reported in his article, "Starting a Hepato-Pancreato-Biliary surgery program from scratch: Closing the gap in West Africa."

In this episode of SurgOnc Today, Dr. Olga Kantor from Brigham and Women's Hospital and Dr. Taiwo Adesoye from MD Anderson Cancer Center discuss the breast track highlights of the SSO 2025 Annual Meeting, focusing on a few potentially practice changing trials presented at the meeting. In case you missed the meeting, be sure to check out the On Demand content, now available at https://learn.surgonc.org/.

In this episode, Dr. Kimberly Brown from The University of Texas at Austin Dell Medical School moderates a discussion with Dr. Thuy Tran from the University of California Irvine about the FDA approval of Lifileucel.

In this episode, Dr. Anna Weiss from the University of Rochester moderates a discussion with Drs. Lola Fayanju at the University of Pennsylvania and Rita Mukhtar at UCSF about surgical management of invasive lobular carcinoma. This histological subtype poses challenges for systemic management and is often underrepresented on conventional breast imaging with concomitant potential for understaging.